000			01723nam a22002777a 4500
001			20241021085741.0
003			OCoLC
005			20241021090308.0
008			241021b |||||||| |||| 00| 0 eng d
010			_a2011923069
020			_a978-94-007-0343-8
020			_a978-94-007-0344-5
040			_cddc
041			_aEnglish
082			_a616.994 HAY
100			_qM.A. Hayat
245			_aTumors of the Central Nervous System _b Gliomas _c Glioblastoma (Part 1.
260			_aLondon | _b Springer Science+Business Media B.V | _c 2011
300			_a456 Pages
300			_aIncludes References and Index
490			_aTumors of the Central Nervous System _vVolume 1
520			_aThe most recent developments in diagnostic and therapeutic aspects of Gliomas (Glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers is included. The identification and validation of brain cancer (glioblastoma) genes are discussed. Role of cancer stem cells in the initiation, progression, and persistence of malignant gliomas is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed.
600			_xGliomas, Biochemical markers, Biomedicine, Central nervous system -- Tumors, Gliomas -- Diagnosis -- Treatment, Medical radiology, Medicine, Nervous system -- Surgery, Oncology, Pathology, Surgery
856			_uDOI 10.1007/978-94-007-0344-5
942			_2ddc _cEB _n0
999			_c29241 _d29241